The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Spectroscopic Evaluation of Intratumoral (IT) Metabolic Modulation (MM) of 5-Fluorouracil (5-FU) by Leucovorin (LV): Correlation of Human Tumor Pharmacokinetics (PK) with Modulation and Tumor Response. SWOG 9006.
 
Hyung-Don Kim
Honoraria - AstraZeneca/MedImmune; Boostimmune; Boryung Pharmaceuticals; Bristol Myers Squibb; Daiichi Sankyo; MSD; Ono Pharmaceutical
Consulting or Advisory Role - Mustbio
Research Funding - Roche/Genentech/Foundation Medicine
 
Soo Ick Cho
Employment - Lunit
Stock and Other Ownership Interests - Lunit
Consulting or Advisory Role - ArtLab
 
Jinho Shin
No Relationships to Disclose
 
Sangwon Shin
Employment - Lunit
 
Taebum Lee
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Jongchan Park
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Sergio Pereira
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Jaewon Hyung
No Relationships to Disclose
 
Chan-Young Ock
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit; Y-Biologics
Consulting or Advisory Role - De novo biotherapeutics; GCCELL; Genome & Company; Idience; Medpacto; PIN therapeutics; Selecxine; Y-Biologics
 
Young Soo Park
No Relationships to Disclose
 
Min-Hee Ryu
Honoraria - Astellas Pharma; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; DAEHWA Pharmaceutical; Daiichi Sankyo; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; DAEHWA Pharmaceutical; Daiichi Sankyo; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); Ono Pharmaceutical (Inst)